1. Home
  2. MLAB vs GFR Comparison

MLAB vs GFR Comparison

Compare MLAB & GFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • GFR
  • Stock Information
  • Founded
  • MLAB 1982
  • GFR 2018
  • Country
  • MLAB United States
  • GFR Canada
  • Employees
  • MLAB N/A
  • GFR N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • GFR
  • Sector
  • MLAB Industrials
  • GFR
  • Exchange
  • MLAB Nasdaq
  • GFR Nasdaq
  • Market Cap
  • MLAB 341.1M
  • GFR 318.9M
  • IPO Year
  • MLAB N/A
  • GFR N/A
  • Fundamental
  • Price
  • MLAB $65.15
  • GFR $5.15
  • Analyst Decision
  • MLAB Buy
  • GFR
  • Analyst Count
  • MLAB 2
  • GFR 0
  • Target Price
  • MLAB $113.50
  • GFR N/A
  • AVG Volume (30 Days)
  • MLAB 126.2K
  • GFR 51.8K
  • Earning Date
  • MLAB 11-06-2025
  • GFR 11-13-2025
  • Dividend Yield
  • MLAB 0.99%
  • GFR N/A
  • EPS Growth
  • MLAB N/A
  • GFR N/A
  • EPS
  • MLAB N/A
  • GFR 2.05
  • Revenue
  • MLAB $242,351,000.00
  • GFR $516,308,125.00
  • Revenue This Year
  • MLAB $5.38
  • GFR N/A
  • Revenue Next Year
  • MLAB $5.25
  • GFR $27.03
  • P/E Ratio
  • MLAB N/A
  • GFR $2.49
  • Revenue Growth
  • MLAB 8.33
  • GFR N/A
  • 52 Week Low
  • MLAB $55.45
  • GFR $3.81
  • 52 Week High
  • MLAB $155.12
  • GFR $8.16
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 47.20
  • GFR 61.27
  • Support Level
  • MLAB $58.83
  • GFR $4.69
  • Resistance Level
  • MLAB $67.91
  • GFR $5.28
  • Average True Range (ATR)
  • MLAB 3.73
  • GFR 0.23
  • MACD
  • MLAB 0.55
  • GFR -0.01
  • Stochastic Oscillator
  • MLAB 64.16
  • GFR 57.89

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.

Share on Social Networks: